Company Search:
Advanced Search
Sponsored Links
Stada Arzneimittel AG Company Snapshot
Stada Arzneimittel AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Stada Arzneimittel AG with three other pharmaceutical manufacturers in Europe: H. Lundbeck A/S of Denmark (2015 sales of 14.59 billion Danish Kroner [US$2.08 billion] of which 22% was Other Pharmaceuticals), Ipsen SA of France (1.52 billion Euro [US$1.61 billion] of which 73% was Specialty Care), and Meda Ab which is based in Sweden (19.65 billion Swedish Kronor [US$2.18 billion] of which 62% was RX).

Sales Analysis. Stada Arzneimittel AG reported sales of 2.12 billion Euro (US$2.24 billion) for the year ending December of 2015. This represents an increase of 2.6% versus 2014, when the company's sales were 2.06 billion Euro. Sales at Stada Arzneimittel AG have increased during each of the previous five years (and since 2010, sales have increased a total of 30%). Sales of Branded Products saw an increase that was more than double the company's growth rate: sales were up 6.6% in 2015, from 800.56 million Euro to 853.60 million Euro. Not all segments of Stada Arzneimittel AG experienced an increase in sales in 2015: sales of Commercial Business fell 0.1% to 43.91 million Euro. (However, this segment's sales were only a very small portion of the company's overall sales). Stada Arzneimittel AG also experienced decreases in sales in Generics (down 0.0% to 1.22 billion Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Stada Arzneimittel AG
  Stock Performance Chart for Stada Arzneimittel AG
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 48.81
(Figures in Euro)
1 Week -0.8%   13 Weeks -1.4%  
4 Weeks 2.4%   52 Weeks 48.8%  
Stada Arzneimittel AG Key Data:
  Ticker: SAZ Country: Germany
  Exchanges: FRA OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 2,115,129,000
(Year Ending Jan 2016).
Employees: 10,532
  Currency: Euro Market Cap: 3,038,675,385
  Fiscal Yr Ends: December Shares Outstanding: 62,255,181
  Share Type: Namensaktie Closely Held Shares: 3,150,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.